Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shogo Tanaka

Showing results (161-170 of 209) with videos related to

Pageof 21
Sort By:
Oncology Letters|February 13, 2024
Downregulated expression of PBRM1 in sarcomatoid hepatocellular carcinomaTerufumi Yoshida, Kazuko Sakai, Masaki Kaibori, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 3, 2021
Postoperative direct-acting antiviral treatment after liver resection in patients with hepatitis C virus-related hepatocellular carcinomaShogo Tanaka, Hiroji Shinkawa, Akihiro Tamori, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 10, 2021
Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinomaHiroya Iida, Masaji Tani, Koji Komeda, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|June 8, 2020
Immunosuppressive tumor microenvironment in occupational cholangiocarcinoma: Supportive evidence for the efficacy of immune checkpoint inhibitor therapyYasunori Sato, Shogo Tanaka, Masahiko Kinoshita, et al.
Anticancer Research|May 6, 2020
Preoperative Neutrophil-to-lymphocyte Ratio Predicts Tumor-infiltrating CD8<sup>+</sup> T Cells in Biliary Tract CancerRyota Tanaka, Kenjiro Kimura, Shinpei Eguchi, et al.
Annals of Surgical Oncology|January 14, 2023
The Prognostic Value of Preoperative Serum Markers and Risk Classification in Patients with Hepatocellular CarcinomaMasato Ota, Koji Komeda, Hiroya Iida, et al.
Anticancer Research|April 30, 2022
Optimal Organ for Patient-derived Xenograft Model in Pancreatic Cancer and Microenvironment that Contributes to SuccessShimpei Eguchi, Kenjiro Kimura, Ken Kageyama, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 28, 2018
The Clinical Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Occupational CholangiocarcinomaMasahiko Kinoshita, Shigekazu Takemura, Shogo Tanaka, et al.
Journal of Hepato-Biliary-Pancreatic Surgery|December 17, 2008
A simple, noninvasively determined index predicting hepatic failure following liver resection for hepatocellular carcinomaTsuyoshi Ichikawa, Takahiro Uenishi, Shigekazu Takemura, et al.
Digestive Surgery|December 24, 2005
Immunohistologic attempt to find carcinogenesis from hepatic progenitor cell in hepatocellular carcinomaTakatsugu Yamamoto, Takahiro Uenishi, Masao Ogawa, et al.
Pageof 21

Showing results (161-170 of 209) with videos related to

Sort By:
Pageof 21
Oncology Letters|February 13, 2024
Downregulated expression of PBRM1 in sarcomatoid hepatocellular carcinomaTerufumi Yoshida, Kazuko Sakai, Masaki Kaibori, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 3, 2021
Postoperative direct-acting antiviral treatment after liver resection in patients with hepatitis C virus-related hepatocellular carcinomaShogo Tanaka, Hiroji Shinkawa, Akihiro Tamori, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 10, 2021
Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinomaHiroya Iida, Masaji Tani, Koji Komeda, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|June 8, 2020
Immunosuppressive tumor microenvironment in occupational cholangiocarcinoma: Supportive evidence for the efficacy of immune checkpoint inhibitor therapyYasunori Sato, Shogo Tanaka, Masahiko Kinoshita, et al.
Anticancer Research|May 6, 2020
Preoperative Neutrophil-to-lymphocyte Ratio Predicts Tumor-infiltrating CD8<sup>+</sup> T Cells in Biliary Tract CancerRyota Tanaka, Kenjiro Kimura, Shinpei Eguchi, et al.
Annals of Surgical Oncology|January 14, 2023
The Prognostic Value of Preoperative Serum Markers and Risk Classification in Patients with Hepatocellular CarcinomaMasato Ota, Koji Komeda, Hiroya Iida, et al.
Anticancer Research|April 30, 2022
Optimal Organ for Patient-derived Xenograft Model in Pancreatic Cancer and Microenvironment that Contributes to SuccessShimpei Eguchi, Kenjiro Kimura, Ken Kageyama, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 28, 2018
The Clinical Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Occupational CholangiocarcinomaMasahiko Kinoshita, Shigekazu Takemura, Shogo Tanaka, et al.
Journal of Hepato-Biliary-Pancreatic Surgery|December 17, 2008
A simple, noninvasively determined index predicting hepatic failure following liver resection for hepatocellular carcinomaTsuyoshi Ichikawa, Takahiro Uenishi, Shigekazu Takemura, et al.
Digestive Surgery|December 24, 2005
Immunohistologic attempt to find carcinogenesis from hepatic progenitor cell in hepatocellular carcinomaTakatsugu Yamamoto, Takahiro Uenishi, Masao Ogawa, et al.
Pageof 21